(Q53144955)
Statements
Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma (English)
Josephine S Gnanandarajah
Nicola J Mason
Julie B Engiles
Falon Gray
Danielle Laughlin
Anita Gaurnier-Hausser
Anu Wallecha